Sun R, Liu Y, Li SY, Shen S, et al. Corrigendum to "Co-delivery of all-trans-retinoic acid and doxorubicin for cancer
therapy with synergistic inhibition of cancer stem cells" [Biomaterials 37 (2015)
405-414]. Biomaterials 2020;263:120373.
PMID: 32937258